Format

Send to

Choose Destination
J Virol Methods. 2013 Nov;193(2):295-303. doi: 10.1016/j.jviromet.2013.06.030. Epub 2013 Jul 5.

Use of cross-reactive serological assays for detecting novel pathogens in wildlife: assessing an appropriate cutoff for henipavirus assays in African bats.

Author information

1
Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK; Institute of Zoology, Zoological Society of London, Regent's Park, London NW1 4RY, UK. Electronic address: alisonpeel@gmail.com.

Abstract

Reservoir hosts of novel pathogens are often identified or suspected as such on the basis of serological assay results, prior to the isolation of the pathogen itself. Serological assays might therefore be used outside of their original, validated scope in order to infer seroprevalences in reservoir host populations, until such time that specific diagnostic assays can be developed. This is particularly the case in wildlife disease research. The absence of positive and negative control samples and gold standard diagnostic assays presents challenges in determining an appropriate threshold, or 'cutoff', for the assay that enables differentiation between seronegative and seropositive individuals. Here, multiple methods were explored to determine an appropriate cutoff for a multiplexed microsphere assay that is used to detect henipavirus antibody binding in fruit bat plasma. These methods included calculating multiples of 'negative' control assay values, receiver operating characteristic curve analyses, and Bayesian mixture models to assess the distribution of assay outputs for classifying seropositive and seronegative individuals within different age classes. As for any diagnostic assay, the most appropriate cutoff determination method and value selected must be made according to the aims of the study. This study is presented as an example for others where reference samples, and assays that have been characterised previously, are absent.

KEYWORDS:

Eidolon helvum; Emerging diseases; HeV; Hendra virus; MCMC; MFI; Markov chain Monte Carlo; Microsphere binding assay; Multiplex; NiV; Nipah virus; ROC; Serology; median fluorescence intensity; receiver operating characteristic

PMID:
23835034
DOI:
10.1016/j.jviromet.2013.06.030
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center